Global Blue [GB] vs Oracle [ORCL] Detailed Stock Comparison
Global Blue
NYSE
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Global Blue wins in 12 metrics, Oracle wins in 7 metrics, with 0 ties. Global Blue appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Global Blue | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.27 | 53.72 | Global Blue |
| Price-to-Book Ratio | 13.90 | 32.00 | Global Blue |
| Debt-to-Equity Ratio | 394.13 | 519.59 | Global Blue |
| PEG Ratio | 21.40 | 32.56 | Global Blue |
| EV/EBITDA | 14.82 | 32.07 | Global Blue |
| Profit Margin (TTM) | 16.60% | 21.68% | Oracle |
| Operating Margin (TTM) | 26.82% | 32.48% | Oracle |
| EBITDA Margin (TTM) | 26.82% | 32.48% | Oracle |
| Return on Equity | 87.24% | 82.38% | Global Blue |
| Return on Assets (TTM) | 8.00% | 7.26% | Global Blue |
| Free Cash Flow (TTM) | $128.13M | $-394.00M | Global Blue |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 62.12% | 69.82% | Oracle |
| Price-to-Sales Ratio (TTM) | 2.94 | 11.41 | Global Blue |
| Enterprise Value | $2.63B | $753.17B | Oracle |
| EV/Revenue Ratio | 4.45 | 13.12 | Global Blue |
| Gross Profit Margin (TTM) | 74.12% | 70.19% | Global Blue |
| Revenue per Share (TTM) | $2 | $21 | Oracle |
| Earnings per Share (Diluted) | $0.41 | $4.34 | Oracle |
| Beta (Stock Volatility) | 0.44 | 1.43 | Global Blue |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Global Blue vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Global Blue | 0.00% | 0.27% | 1.35% | 0.67% | 20.22% | 4.32% |
| Oracle | 1.38% | -4.80% | -0.73% | 50.26% | 39.07% | 42.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Global Blue | 62.12% | 50.10% | -29.93% | -23.18% | -23.18% | -23.18% |
| Oracle | 69.82% | 216.64% | 308.38% | 530.99% | 950.07% | 1,732.33% |
Performance & Financial Health Analysis: Global Blue vs Oracle
| Metric | GB | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.49B | $654.91B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 97,816 | 10,558,180 |
| 90 Day Avg. Volume | 57,639 | 10,423,740 |
| Last Close | $7.49 | $236.37 |
| 52 Week Range | $4.40 - $8.00 | $118.86 - $260.87 |
| % from 52W High | -6.38% | -9.39% |
| All-Time High | $15.93 (Aug 24, 2020) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -52.98% | -9.39% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.11% |
| Quarterly Earnings Growth | 0.40% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.22% |
| Operating Margin (TTM) | 0.27% | 0.32% |
| Return on Equity (TTM) | 0.87% | 0.82% |
| Debt to Equity (MRQ) | 394.13 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.54 | $7.29 |
| Cash per Share (MRQ) | $0.52 | $3.99 |
| Operating Cash Flow (TTM) | $187.40M | $20.82B |
| Levered Free Cash Flow (TTM) | $101.86M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: Global Blue vs Oracle
| Metric | GB | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.27 | 53.72 |
| Forward P/E | 21.40 | 32.56 |
| PEG Ratio | 21.40 | 32.56 |
| Price to Sales (TTM) | 2.94 | 11.41 |
| Price to Book (MRQ) | 13.90 | 32.00 |
| Market Capitalization | ||
| Market Capitalization | $1.49B | $654.91B |
| Enterprise Value | $2.63B | $753.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.45 | 13.12 |
| Enterprise to EBITDA | 14.82 | 32.07 |
| Risk & Other Metrics | ||
| Beta | 0.44 | 1.43 |
| Book Value per Share (MRQ) | $0.54 | $7.29 |
Financial Statements Comparison: Global Blue vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GB | ORCL |
|---|---|---|
| Revenue/Sales | $148.01M | $15.90B |
| Cost of Goods Sold | $38.30M | $4.74B |
| Gross Profit | $109.71M | $11.16B |
| Research & Development | $-13.65M | $2.65B |
| Operating Income (EBIT) | $38.52M | $5.19B |
| EBITDA | $56.10M | $7.00B |
| Pre-Tax Income | $24.91M | $4.15B |
| Income Tax | $7.71M | $725.00M |
| Net Income (Profit) | $17.20M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GB | ORCL |
|---|---|---|
| Cash & Equivalents | $144.16M | $10.79B |
| Total Current Assets | $522.25M | $24.58B |
| Total Current Liabilities | $516.72M | $32.64B |
| Long-Term Debt | $646.84M | $96.83B |
| Total Shareholders Equity | $167.91M | $20.97B |
| Retained Earnings | $-914.31M | $-15.48B |
| Property, Plant & Equipment | $72.75M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GB | ORCL |
|---|---|---|
| Operating Cash Flow | $44.91M | $5.93B |
| Capital Expenditures | $-2.28M | N/A |
| Free Cash Flow | $15.31M | $-2.92B |
| Debt Repayment | $-4.10M | $-6.07B |
| Common Stock Repurchase | $0 | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | GB | ORCL |
|---|---|---|
| Shares Short | 62,684 | 20.69M |
| Short Ratio | 1.84 | 1.58 |
| Short % of Float | 0.00% | 0.01% |
| Average Daily Volume (10 Day) | 97,816 | 10,558,180 |
| Average Daily Volume (90 Day) | 57,639 | 10,423,740 |
| Shares Outstanding | 232.19M | 2.81B |
| Float Shares | 192.91M | 1.64B |
| % Held by Insiders | 0.01% | 0.42% |
| % Held by Institutions | 0.09% | 0.45% |
Dividend Analysis & Yield Comparison: Global Blue vs Oracle
| Metric | GB | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |